News in brief: Canopy expands Australian portfolio; Neurotech CEO departs; Elixinol completes US sale by Adam Sheldon September 8, 2026September 9, 2026 Nasdaq and Toronto-listed Canopy Growth has expanded its Australian portfolio with a suite of new products, […]
Elixinol cuts H1 loss and announces deal to sell US hemp business by Adam Sheldon September 2, 2026September 3, 2026
Financial news in brief: Elixinol record quarter; Avecho identifies new trial sites by Steve Jones July 29, 2026July 30, 2026
News in brief: Cannaponics raise tops $2.5m; Avecho receives $1.98m R&D incentive; Elixinol backs capital raising plans by Adam Sheldon May 27, 2026June 8, 2026
E-commerce surge lifts Elixinol margins in FY25 but losses deepen by Adam Sheldon March 3, 2026March 5, 2026
Elixinol records first underlying operating cash flow positive quarter by Adam Sheldon February 2, 2026February 3, 2026
Elixinol names new chair in pursuit of ‘sustainable and profitable business’ by Steve Jones December 2, 2025February 21, 2026
News in brief: Elixinol names new CEO; Aurora flags MedReleaf growth; InhaleRx R&D tax rebate; ODC to ‘share insights’; Tilray appoints new Australian director by Steve Jones June 20, 2025June 26, 2025
News in brief: Carmen Doran to chair NZMCC; ECS Botanics tips record harvest; Elixinol and Epsilon raise capital by Martin Lane and Steve Jones May 21, 2025May 21, 2025
